Brought to you by 
Delcath Systems nets $2.17mm in follow-on
13 Aug 2003
Executive Summary
Delcath Systems (perfusion system that delivers chemotherapeutics specifically to the liver) raised net proceeds of $2.17mm in a follow-on offering. It initially sold 677.4k units, each consisting of five shares of common stock plus five callable five-year warrants (each for the purchase of one common share at $0.775, or 25% of the $3.10 unit offering price). Later the underwriters exercised a greenshoe option, buying 508k common shares plus an equal number of warrants.
Deal Industry
- Medical Devices
-
Pharmaceuticals
-
Drug Delivery
- Site Specific
-
Drug Delivery
-
Medical Devices
- Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Financing
- FOPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Delcath Systems nets $2.17mm in follow-on
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice